CSA Medical is the innovator and developer of a novel, medical device therapy for COPD with Chronic Bronchitis that delivers extremely cold (-196°C) liquid nitrogen "metered cryospray" to damaged airways. This breakthrough, first of its kind therapy is performed under direct bronchoscopic visualization on an outpatient basis. The RejuvenAir System is an investigational device and not currently commercially available in the United States.